TNFRSF1B and primary cutaneous T-cell non-Hodgkin lymphoma: At present, abnormal expression of Tnfrsf1b has been identified in at least 25 tumors, such as colon cancer, ovarian cancer, cutaneous T-cell lymphoma (CTCL), etc (61–64).